Results 31 to 40 of about 12,584 (301)

Atherogenic Dyslipidemias: Unmet Needs and the Therapeutic Potential of Emerging and Novel Approaches and Drugs [PDF]

, 2023
Innovative lipid-modifying agents are valuable resources to improve the control of atherogenic dyslipidemias and reduce the lipid-related residual cardiovascular risk of patients with intolerance or who are not fully responsive to a consolidated standard
Stefano Genovese, Damiano Baldassarre, Marco Scatigna, Stefano Capri, Giulio Pompilio, José Pablo Werba, Alessandra Romandini   +6 more
core   +1 more source

Risk factors for cardiovascular disease in children on chronic hemodialysis: Traditional (general) risk factors, Part I [PDF]

Vojnosanitetski Pregled, 2016
nema
Šulović Ljiljana S.
doaj   +1 more source

Psoriasis and Dyslipidemia [PDF]

Materia Socio Medica, 2015
Psoriasis is a chronic skin ailment, which can be connected with other ailments including dyslipidemia.Research included 70 patients affected by psoriasis. Both genders, above 18 years of age. Average age of the respondents was 47.14 (SD= ±15.41), which consisted of 36 men (51.43%) and 34 women (48.57%). The average duration of psoriasis was 15.52 (SD=
Salihbegovic, Eldina Malkic, Hadzigrahic, Nermina, Suljagic, Edin, Kurtalic, Nermina, Hadzic, Jasmina, Zejcirovic, Alema, Bijedic, Midheta, Handanagic, Alma   +7 more
openaire   +2 more sources

Frequency of Dyslipidemia In Type 2 Diabetic Patients In Karachi

Journal of Bahria University Medical and Dental College, 2019
Objective: To find out the frequency of dyslipidemias in type 2 diabetic patients. Study Design and Setting: This was cross-sectional study and conducted in a different clinics in Karachi during 3 months period. Methodology: Those patients who fulfilled
Sehrish Shafique, Daud Mirza, Summayya Shawana, Shahneela Tabassum, Naveed Faraz   +4 more
doaj   +1 more source

Long-term effects of ambient air pollutants to blood lipids and dyslipidemias in a Chinese rural population [PDF]

, 2019
Both air pollution and dyslipidemias contributed to large number of deaths and disability-adjusted life lost years. Long-term air pollution exposure was related to changed blood lipids and risk of dyslipidemias.
Liu, Yisi, Liu, Feifei, Mao, Shuyuan, Xiang, Hao, Li, Na, Chen, Gongbo, Wang, Chongjian, Liu, Suyang, Lu, Yuanan, Guo, Yuming, Li, Shanshan   +10 more
core   +1 more source

Experience With Performing Rheocarna Therapy via the Single‐Needle Method for Treatment of Chronic Limb‐Threatening Ischemia

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction This study investigated the safety and efficacy of single‐needle Rheocarna therapy for chronic limb‐threatening ischemia (CLTI) with wounds. Methods Six patients with CLTI involving ulcers unresponsive to revascularization underwent single‐needle Rheocarna treatment.
Yasutaka Yamauchi, Rie Tanaka, Reona Kawahira, Shingo Nabeta, Kouhei Naoi, Kazuhito Kitajima, Akira Wada, Tomonari Takagi, Norihiko Ohura, Akira Miyamoto   +9 more
wiley   +1 more source

Diet and Lipid-Lowering Nutraceuticals in Pediatric Patients with Familial Hypercholesterolemia

Children
Familial hypercholesterolemia is a genetically determined disease characterized by elevated plasma total and LDL cholesterol levels from the very first years of life, leading to early atherosclerosis. Nutritional intervention is the first-line treatment,
Maria Elena Capra, Giacomo Biasucci, Giuseppe Banderali, Andrea Vania, Cristina Pederiva   +4 more
doaj   +1 more source

Transferrin receptor 1‐mediated iron uptake supports thermogenic activation in human cervical‐derived adipocytes

FEBS Letters, EarlyView.
In this study, we found that human cervical‐derived adipocytes maintain intracellular iron level by regulating the expression of iron transport‐related proteins during adrenergic stimulation. Melanotransferrin is predicted to interact with transferrin receptor 1 based on in silico analysis.
Rahaf Alrifai, Mizuki Seo, Gyath Karadsheh, Fachrur Rizal Mahendra, Máté Á Demény, Ferenc Győry, János András Mótyán, László Fésüs, Endre Kristóf, Rini Arianti   +9 more
wiley   +1 more source

LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias[S]

Journal of Lipid Research, 2014
We report the design of a targeted resequencing panel for monogenic dyslipidemias, LipidSeq, for the purpose of replacing Sanger sequencing in the clinical detection of dyslipidemia-causing variants.
Christopher T. Johansen, Joseph B. Dubé, Melissa N. Loyzer, Austin MacDonald, David E. Carter, Adam D. McIntyre, Henian Cao, Jian Wang, John F. Robinson, Robert A. Hegele   +9 more
doaj   +1 more source

A wide next-generation-sequencing panel improves the molecular diagnosis of dyslipidemias

, 2020
Introduction: Dyslipidemias are common clinical conditions associated to cardiovascular diseases. Among these, Familial Hypercholesterolemia (FH) and severe Hypertriglyceridemia (sHTG) are the most frequent ones.
Giacobbe C., Cardiero G., Forte F., Calcaterra I., Iannuzzo G., Palma D., Buonaiuto A., Fortunato G., Di Taranto M. D., Maione G.   +9 more
core   +1 more source